Search Immortality Topics:

Page 20«..10..19202122..3040..»

Advanced Stem Cells & Regenerative Medicine

Posted: June 11, 2018 at 5:43 am

Stem Cell Conference Highlights & Benefits:

Keynote Sessions on Stem CellOral presentations on Stem CellYoung Researcher Forums Poster Presentations on Stem CellVideo Presentations on Stem CellE-poster Presentations on Stem CellHonorable Guests Presentations Exhibitions on Stem CellCME Felicitations and CertificationsFree Abstract Publication & DOIFree Lunch and NetworkingQuestionnaires on Stem Cell

Early Deadline for Abstract Submission closing soon

Conference Topics:

The Importance of stem cell conference has given us the Possibility to bring the assembling in Prague, Czech Republic. Since its commencement in 2012 Stem cell series has witnessed around 890 researchers of great abilities andExceptional research presentationsfrom around the world. Attention of stem cells and its application widely prevalent among the Common Population. Stem cells are applicable to understanding the cancer the global stem cells market is segmented according to product type, sources, application, end users and geography and helpful to welfare of mankind. Stem cell medical aid is most promising treatment for diseases likeParkinsons diseases, Alzheimer’s disease, illness connected disease likeleukaemia, Parkinsons,Myelodysplastic Syndromes, Lymphomas, alternative Disorders.

Sub Track:

Reganerative Medicine Conferences | Genetics Conferences | Life Sciences Meetings | Rehabilitation Engineering Meets

Track 3: Regenerative MedicineDiscovery of stem cells lead to a wide new branch of medicine which is known as regenerative medicine. Regenerative medicine focuses to help the body to form new functional tissue to substitute lost or defective ones. Regenerative medicine tends to provide therapeutic treatment for conditions where current therapies are inadequate. Regenerative medicine uses the idea of tissue engineering & stem cell technology.

Sub Track:

Tissue Engineering Meetings | Hematopoeitic Stem Cells Expo | Advanced Stem Cells Meets | Cancer Stem Cell Conferences

Track 4: Stem Cell TherapyStem cell therapy is becoming the main point of healthcare of India. The ability of stem cells self-renewing offers the potential for generation of tissues that can replace the damaged areas and dead tissues with minimal side effects. It is predicted by the researchers and scientists that adult and embryonic cells would be able to treat cancer and many more disorders soon.

Sub Track:

Embryonic Stem Cells Expo | Stem Cells Conferences | Stem Cell Niche Events | Pluripotent Stem Cells Meets | Stem Cell Transplant Conferences

Track 5: Stem Cell NicheThe term niche here refers to where the stem cells reside & get activated to differentiate and proliferate. Niche cells show a strong interaction in keeping all the dynamic system (bone marrow niche) functional. They are the source of secreted or cell surface factor which includes member of Notch, Wnt, Fibroblast growth factor (FGR), Transforming Growth Factor (TGF)-beta, Stem Cell Factor (SCF) and Chemokine familiescontrols stem cell renewal, maintenance & survival.Sub Track:

Stem Cells Events | Stem Cells Meetings | Rehabilitation Engineering Expo | Advanced Stem Cell Conferences | Regenerative Medicine Meetings

Track 6: Cancer Stem CellRarely immortal cells are Cancer Stem Cells which is observed within a tumour that has the ability to both self-renew by dividing and give rise to many new cell types that constitute the tumour. Cancer stem cells are small cluster of tumour cells with the ability of tumorogenecity, dedifferentiation, chemo and radiotherapy resistance which ultimately result in tumour relapse.

Sub Track:

Tissue Science Meetings | Genetics Conferences | Stem Cell Expo | Stem Cell Conferences | Stem Cells Meetings

Track 7: Tissue EngineeringTissue engineering is the interdisciplinary field that combines principles of biology and medicine with engineering. Here, Tissue Engineering is the process to repair or replace damaged tissues and enhances natural regeneration. Source of cells for tissue engineering includes embryonic stem cells, adult stem cells, and progenitor cells. Design and construction of functional components that can be utilised for maintenance, regeneration, replacement of damaged biological tissues.

Sub Track:

Tissue Science Meetings | Advanced Stem Cells Conferences | Stem Cells Event | Stem Cell Expo | Rehabilitation Engineering Conferences

Track 8: Rehabilitation EngineeringRehabilitation Engineering is the application of engineering principles which is used for designing and developing technological solutions and devices to assist people with disabilities. Individuals with impairments in the functional parts of body such as mobility, hearing, vision and cognition are concerned under the subject of Rehabilitation Engineering. The main task of Rehabilitation Engineering gives a supportive mechanism for the humans with physical and cognitive functions lost.

Sub Track:

Artificial Skin Expo | Regenerative Medicine Meetings | Pluripotent Stem Cells Events | Adult Stem Cell Meets

Track 9: Patient Specific Drug Discovery

The pharmaceutical industry faces innumerable difficulties in the production of novel compounds. Patient-specific drug discovery is the process of inventing new drugs by keeping in concern about the pros and cons and the physical conditions of the patient. Medicines are discovered on the basis of proper ingredients available from conventional solution or some coincidental discoveries.

Sub Track:

Stem Cell Congress | Hematology Confernces | Stem Cell Therapy Meets | Advanced Stem Cells Conferences | Stem Cells Expo

Track 10: Tissue Regeneration

The revitalization of damaged cells and tissues involves cell proliferation. Tissue regeneration is the process of renew the cells injured tissues with the help of regenerative medicines. Non injured tissues have expanded cells in the overtime formation whereas new cells formed when injuries replace expanded cells in diminishing the wounded area leaving some scars in skin.

Sub Track:

Stem Cell Therapy Meets | Advanced Stem Cells Conferences | Stem Cells Conferences | Tissue Science Coneferences | Regenerative Medicine Conferences

Track 11: Genetically Modified Stem Cell Therapy

It is a procedural technique which makes use of the genetic cell in modifying stem cells for treating or preventing disease. Genetically Modified cell therapy generally influences the course of various genetic diseases at DNA/RNA level. In Gene Therapy stem cells used are well founded which has some complex results for treating many diseases and many are not curable.

Sub Track:

Stem Cells Conferences | Advanced Stem Cells Conferences | Stem Cell Meetings | Stem Cell Therapy Expo | Tissue Engineering Meets

Track 12: 3D Bioprinting & Biofabrication

The term 3D printing refers to the machine which gives the information of two dimensional images in the form of three dimensional objects. Computer controls the layer of materials to form a three dimensional object by providing the geometry of the object. 3D Bioprinting helps the process of Tissue Engineering by providing comprehensive information of the images & structure analysis of the image.

Sub Track:

Molecular Biology Meets | Cell Biology Expo | Stem Cell Banking Expo | Regenerative Stem Cells Meetings | Stem Cell Conference | Regenerative Medicine Conference

Track 13: Illness and Ageing

Injury or sickness of individuals makes their cells to die or dysfunctional. Ageing is the demonstration of the internal depletion of stem cells. It shows that human beings could not without stem cells. For a diverse group of treatment purpose adult stem cells can be used. Adult Stem cell resides in-vivo in the form of self- renewing pools & helps in repairing/replacement of damaged tissues over the survival of of the organism.

Sub Track:

Hematology Stem Cells Conferences | Stem Cells Meetings | Dental Stem Cell Congress | Pluripotent Stem Cells Conferences

Track 14: Nanotechnology in Stem Cells

Nanotechnology is the branch of technology that deals with small things that are less 100 nm in size. Here, to tackle the position of stem cells for some biotherapeutic applications we need to work at the size scales of molecules & processes that govern stem cells fate. Nanotechnology and nanoscience offers immense benefits to humans with effective amalgamation of nanotechnology & stem cells.

Sub Track:

Bone Marrow Transplantation Meets | Umbilical Cord Blood Expo | Stem Cells Conferences | Stem Cells Meetings

Track 15: Hematopoietic Stem Cells Transplantation

During embryonic development Hematopoietic Stem cells starts growing. These cells are basically found in umbilical cord blood and bone marrow. Hemati is a Greek prefix =blood, poesies/poietic suffix= formation and expresses CD34. Self-renewing, multipotent cells progenitor cells gives rise to blood cells (Haematopoiesis). It maintains the production of blood cells throughout the life. Bone marrow Transplantation has become Hematopoietic Stem Cell Transplantation (HSCT) after the introduction of peripheral blood and umbilical cord stem cells. This HSCT has become a standard treatment for malignant (e.g. Multiple myeloma, ovarian cancer) and non-malignant blood disorders (e.g. amyloidosis, Autoimmune Disorders). Hematopoietic Stem Cells Transplantation is a unique effective treatment which provides normal `stem cell production for many malignancies and disorders.

Sub Track:

Stem Cell Biotechnology Meets | Regenerartive Medicine Conferences | Stem Cell Meetings | Stem Cells Expo

Track 16: Stem Cells Technology

Stem cell technologies is the process of developing, manufacturing, selling product and providing services meanwhile supporting tutorial and industrial scientists. The team of stem cell analysis and development alliance academic and industrial partners to develop, manufacture and distribute products. In the world of biotechnology market stem cell has helped many scientific technologies to born in tutorial analysis setting to succeed. The corporate world makes a specialised way of growing and developing culture media, cell separation product, instruments and various reagents to be used. Stem cell biotechnology is necessary for regenerative medicine.

Sub Track:

Cord Blood Banking Meets | Neural Stem Cells Congress | Umbilical Cord Blood Banking Expo | Stem Cell Conferences

Track 17: Reprogramming Stem Cells: Computational Biology

Computational Biology is the branch of biology which involves the development of data-analytics and theoretical methods. It also includes the application of computer science to the understanding of mathematical modelling and computational simulation techniques regarding the studies of biological behavioural and social systems. Understanding dynamic cellular processes such as development, reprogramming, repair, differentiation is all fundamentally about the field of stem cell biology and regenerative medicine. Modern high throughput molecular profiling technologies are the vital approach to address the questions of profiling of tens of thousands of genes products in a single experiment. In these cases, bioinformatics takes the chance to interpret the information produced by these technologies.Sub Track:

Cord Tissue Expo | Stem Cell Congress | Regenerative Medicine Conferences | Advanced Stem Cells Meetings

Track 18: Stem Cell apoptosis and Signal Transduction

By induction of apoptosis self-renewal and proliferation of stem cell population is controlled. Apoptosis of stem cells is a dynamic process which changes accordingly to the response to environmental conditions. The number of stem cells are always balanced between the lost through differentiation and to the gained through proliferation. Self-renewal and multiplication is controlled to some degree by the affectation of apoptosis. Because of natural conditions apoptosis of immature microorganisms is accepted to be dynamic.Sub Track:

Stem Cell Summit | Stem Cell & Regenerative Medicine Research | Stem Cell Conferences | Stem Cells Congress

Track 19: Tissue Preservation & Bio Banking

Tissue preservation is the process by which a tissue or group cells are kept alive outside the organisms body. Adult stem cells are collected from adipose tissue and they are banked. These stem cells are said that they do not require umbilical cord & fatty tissue contains. Stem cells have been shown to regenerate injured tissue such as cartilage, heart and even kidney tissue. Bio banking is a type of bio repository which stores biological samples of humans generally. In bio banking blood is collected from fogeys and shipped to a wire bank. Samples are kept for preservation at -196 degrees in centigrade and then they are processed, tested. It is believed that stem cells will treat around 70 blood related & genetic disorders together including thalassemia, anaemia, leukaemia and immune diseases.

Sub Track:

Track 20: Stem Cell Product Development & Commercialization

This convention presents business opportunities, challenges and prospective planning to prevail over challenges faced in all areas of stem cell & regenerative medicine researches including the applications, regulations, manufacturing, product development, funding, and the marketing of Stem Cells & Regenerative Medicine. Come attend learn what currently commercially viable categories.

Sub Track:

Advanced Stem Cell & Regenerative Medicine Market Overview:

The market was evaluated at $42.24 billion in 2016 and is expected to reach a value of $68.72 billion by 2022, witnessing a CAGR of 8.52% during the predicted period, 2017-2022.

Global Market Study of Stem Cells & Regenerative Medicine:

USA: The regenerative medicine & stem cell market is assuming to reach $38.70 billion by the year 2022 from $ 13.33 billion in 2016 at a CAGR of 23.56%.

Middle East: The regenerative medicines market is expected $ 40.55 billion revenue in 2022 from $ 17.03 billion revenue in 2016.

Here is the original post:
Advanced Stem Cells & Regenerative Medicine

Recommendation and review posted by G. Smith

Transhumanism: Genetic Engineering of Man – the New …

Posted: June 11, 2018 at 5:41 am

Barbara H. Peterson

Farm Wars

There is a move afoot to reprogram humanity. To redefine it in the limited terms of scientific understanding, place it in a box, and then, all wrapped up in a pretty package, attempt to deliver this convoluted mess to us as progress.

There are those who think that, given the chance, they could and should genetically manipulate the earth and the creatures that inhabit it, including man, to suite a purpose of their own imaginings. They want to experiment on all of our precious resources, turn our rivers into streams of pollution, and take each and every living thing on earth and use it to create something better.

According to whose design? Well, the so-called scientific one, of course. And if this means combining cows and humans, goats and spiders, man and machine in order to achieve the goal? Well, so be it. After all, the only thing that is important is the end result. And the end result is that a few will obtain immortality or so they think. And if a few eggs get broken in the process, well, that is the price paid for success.

This is Transhumanism the natural culmination of something called reprogenetics. Some call it designer evolution.

What is Reprogenetics?

In short, reprogenetics is the genetic engineering of man to create a human race according to scientific design. Here is a definition from Lee M. Silver, author of the book Remaking Eden: How Genetic Engineering and Cloning Will Transform the American Family (1998).

Reprogenetics will involve advances in a number of technologies not yet achieved, but not inherently impossible. Among these are improvements in interpreting the effects of different expressions of DNA, the ability to harvest large numbers of embryos from females, and a far higher rate of reinsertion of embryos into host mothers. The end result, according to Silver, is that those parents who can afford it will be able to pick out the genetic characteristics of their own children, which Silver says will trigger a number of social changes in the decades after its implementation. Possible early applications, however, might be closer to eliminating disease genes passed on to children.

According to Silver, the main differences between reprogenetics and eugenics, the belief in the possibility of improving the gene pool which in the first half of the 20th century became infamous for the brutal policies it inspired, is that most eugenics programs were compulsory programs imposed upon citizens by governments trying to enact an ultimate goal.

It becomes quite apparent, after reading the quote above, that the main difference between reprogenetics and eugenics is consent, according to Lee M. Silver. Eugenics forced. Reprogenetics consented to. Same thing, different mode of action. From the forced culling of those deemed inferior to creating a superior race through genetic engineering, the end result is the same. Those deemed inferior are eventually culled from the system using DNA manipulation techniques.

Eugenics renamed and defined as scientific progress. A life-saving technique that can reprogram the human race and create the ideal human family. Thats the spin. Im sure the promoters said the same thing about nuclear energy. Dangerous? Naw. We know what we are doing. Arrogance.

So, lets take this technique of reprogramming humanity through reprogenetics/eugenics and dig a little deeper, shall we?

Meet Genome Compiler

OUR STORY:

Genome Compiler is built on the idea that biology is information technology. We can design and program living things the same way that we design computer code. Genetic designers today are still writing in 1s and 0s they lack the missing tools to design, debug, and compile the biological code into new living things.

At Genome Compiler, weve built just that a simplified solution for designing DNA.

We are inspired by the breakthrough research done by the JCVI and Harvard with their achievement of whole bacterial genome engineering, as required for functional changes in the form of new codes, new amino acids, safety and virus-resistance and a vision of making biological design easier, cheaper, and open to people outside the research labs.

Genome Compiler Corporation New

After all, when all is said and done, DNA is simply DNA, and mixing it up has no inherent consequences, right? That is what we are supposed to believe. And who is to say what is human and what is not? Arent we all made of molecules?

The Transhumanist Agenda

The following quote pretty much sums up the Transhumanist attitude towards the relationship between you, me, the computer I am using to write this, and the chair I am sitting on:

Whether somebody is implemented on silicon or biological tissue, if it does not affect functionality or consciousness, is of no moral significance. Carbon-chauvinism, in the form of anthropomorphism, speciesism, bioism or even fundamentalist humanism, is objectionable on the same grounds as racism.

A Transhumanist Manifesto [Redux]

If we want to be half human, half frog, isnt that our right? If everything is the same, then anything goes. This is put forth in the guise of freedom of choice, freedom from disease, and freedom from suffering. Actually, this is a sure road to slavery, disease and suffering, and a path towards erasing who we are and simply becoming just another set of molecules on planet earth, much like a chair, or car, or vacuum cleaner.

The Transhumanist goal, based on this oneness of all things biologically and artificially created, is to use science and technology to control evolution of the species, because science is safer than nature.

Biological evolution is perpetual but slow, inefficient, blind and dangerous. Technological evolution is fast, efficient, accelerating and better by design. To ensure the best chances of survival, take control of our own destiny and to be free, we must master evolution.

A Transhumanist Manifesto [Redux]

This mastering of evolution is accomplished through a scientific dictatorship:

Scientific Dictatorship is the utopian concept of scientific managerism whereby all facets of political, social and economic life are managed solely by the scientific method and dictates of science. (Patrick Wood)

And precaution? Well, that goes out the window. Quote from Dr. Max Moore, a leader in Transhumanism:

Many factors conspire to warp our reasoning about risks and benefits as individuals. The bad news is that such foolish thinking has been institutionalized and turned into a principle. Zealous pursuit of precaution has been enshrined in the precautionary principle. Regulators, negotiators, and activists refer to and defer to this principle when considering possible restrictions on productive activity and technological innovation.

In this chapter, I aim to explain how the precautionary principle, and the mindset that underlies it, threaten our well-being and our future.

http://www.maxmore.com/perils.htm

Dr. Max More, the author of The Principles of Extropy, is one of the top leaders of the Transhumanist movement, and the two are tightly interconnected. One could consider Extropy as as the metaphysical backbone of Transhumanism. (Patrick Wood)

In other words, according to one of the top leaders in the transhumanist movement, the precautionary principle actually endangers us. How convoluted can you get?

So, throwing caution aside, onward we go by experimenting through DNA manipulation to create a world where the pseudo-science of a scientific dictatorship rules supreme.

Here are just some examples of DNA mixing going on right now:

http://s-special4you.com/10-insane-cases-of-genetic-engineering/

The future of war is going to look really, really weird. The super soldier research that DARPA (the Defense Advanced Research Projects Agency) is working on right now is unlike anything we have ever seen before. If DARPA is successful, and if the American people dont object, the soldiers of the future will be genetically modified transhumans capable of superhuman feats.

http://www.jimstonefreelance.com/vanilla/discussion/322/u-s-super-soldiers-of-the-future-will-be-genetically-modified-transhumans-capable-of-superhuman-/p1

We are in for a lot more than those who actually believe in the medical benefits of DNA manipulation bargained for. All these examples are leading us down the road to the real Transhumanist agenda:

Transhumanism is the application of science to the condition of man to achieve characteristics of immortality, omniscience and omnipresence, among others, and to produce a God-like race of post-humans. (Patrick Wood)

Yes, there are people who are actively attempting a complete takeover of humanity in order to set themselves up as supreme beings. To transcend physical boundaries by intermixing any DNA that so-called scientists think is appropriate, discard the precautionary principle as too dangerous for proper evolution, full speed ahead, meld man, machine, computer, and eventually, transcend to Godhood. It doesnt matter if it works, it doesnt matter if it is sane, it is a plan in the works. And the people who are involved think that they know how to create a better man.

Here is a bit of the history of Transhumanism and its ties to eugenics:

Julian Huxley, brother of Aldous who authored Brave New World, first used this word (1957): Transhumanism. Huxley was a member of the British Eugenics Society, eugenics being the foundation of Transhumanism.

Quote:

Eugenics is a science dedicated to a Darwinist philosophy applied to humanity, that the strong should thrive and evolve, while the weak are culled and eradicated.

Eugenics rests on a necessity of there being superior and inferior genetic pools in the human population. It might be very socially unacceptable to speak publicly of there being some races, ethnic or cultural groups who are inferior to the rest, yet in secrecy this is exactly what elite Eugenicists believe.

The public is guided to love the idea of Transhumanism by being persuaded that it is not a goal attached to race or ethnicity, but simply a means of bettering all of humanity. This is quite untrue.

Elite Transhumanists have no desire to evolve all humankind, their goal is one which seeks to advance only their own bloodlines and to leave the rest in disadvantage to them so that these unfortunate ones have no choice but to become their slaves, their lab animals and their labor force.

The lowest strata are reproducing too fast. Therefore they must not have too easy access to relief or hospital treatment lest the removal of the last check on natural selection should make it too easy for children to be produced or to survive; long unemployment should be a ground for sterilization.

Julian Huxley

http://www.zengardner.com/transhumanism-techno-eugenics-usurping-humanity/

And wouldnt you know it, the Rockefeller Foundation can be found providing funding for the eugenics movement:

In 1927, the Rockefeller Foundation provided funds to construct the Kaiser Wilhelm Institute for Anthropology, Human Heredity, and Eugenics in Berlin, which came under the directorship of the appropriately named Eugen Fischer. Adolf Hitler read Fischers textbook Principles of Human Heredity and Race Hygiene while in prison at Landsberg and used eugenical notions to support the ideal of a pure Aryan society in his manifesto, Mein Kampf (My Struggle).

http://www.eugenicsarchive.org/eugenics/topics_fs.pl?theme=41

What was termed in its early stages as a pure Aryan society, is now being repackaged as a pure Transhumanist society in which DNA is programmed to conform to the design of a scientific dictatorship, and sold as the salvation of man. The New Age of ascention. Same story, new box. When will we learn?

And the motivation for all of this? As usual, there are many:

Profit

Human transcendence

Control

Power

Eternal life immortality

The justification? Thats easy: Progress always requires sacrifice. To quote a famous activist:

Human progress is neither automatic nor inevitable. Even a superficial look at history reveals that no social advance rolls in on wheels of inevitability. Every step toward the goal of justice requires sacrifice, suffering, and struggle; the tireless exertions and passionate concern of dedicated individuals. Without persistent effort, time itself becomes an ally of the insurgent and primitive forces of irrational emotionalism and social destruction. This is no time for apathy or complacency. This is a time for vigorous and positive action. (MLK Jr.)

Except in this case, it is not the beneficiary of the technologys sacrifice that is required, but the sacrifice of dedicated and ignorant servants and an unwitting populace. We sacrifice our health, wealth, and minds to the slavery of junk science that says it is okay to maim, torture, and impoverish millions so that a few may gain. It is okay to run widespread experiments on humanity so that a few may benefit from those experiments and transcend to a God-like state and rule over the universe. It doesnt matter if you believe it, or if I believe it. It doesnt have to be rational or sane. What matters is that people with enough money and power to go forth with this agenda do believe it, are working steadily towards it, and know how to market it in order to get the public to accept it as beneficial.

Transhumanism is being sold to the public as bringing forth a new age of enlightenment. This story is as old as the Biblical account of the Garden of Eden, where Lucifer, masquerading as the angel of light, tells Eve that he knows a better way. It is also being touted as an extension of Darwinism: another step in the evolutionary process the better, scientific way, because the slow, biological way is simply too dangerous and inherently unpredictable.

Humans are about to decommission natural selection in favour of guided evolution. Darwinian processes gave humanity a good start, but Homo sapiens can be improved. Owing to advances in genetics, cybernetics, nanotechnology, computer science, and cognitive science, humans are set to redefine the human condition. Future humans can look forward to longer lives, enhanced intelligence, memory, communication and physical skills, and improved emotional control. Humans may eventually cease to be biological and gendered organisms altogether, giving rise to the posthuman entity. Human enhancement will irrevocably alter social arrangements, interpersonal relationships, and society itself. And theres also the added potential for nonhuman enhancement.

http://www.sentientdevelopments.com/2007/01/must-know-terms-for-21st-century_11.html

Much better to trust in man and his scientific knowledge to create a better evolutionary path, and manipulating our DNA is that way. And just who comes to mind as an expert at manipulating DNA and public perception?

The Monsanto Connection

Remember when Craig Venture of Atlas Venture created Synthia, a synthetic life form, and partnered with Monsanto?

Monsanto and Atlas Venture

And now Monsanto has recently signed a deal with Atlas Venture for funding of, well, who knows? Monsanto does. And Monsanto isnt telling. But we do know that it will most likely be some sort of disruptive innovation because that is Atlas Ventures specialty. Atlas Venture is an early stage investment firm dedicated to financing disruptive innovation in Life Sciences and Technology.

In the Grip of Mad Scientists: Business as Usual for Monsanto, Fort Detrick, and Atlas Venture

Well, it appears that Monsanto and Atlas Venture are working on a new type of genetic engineering using RNA. Is this the disruptive technology that I mentioned in my article cited above?

Generations of high school kids have been taught that only about 3 percent of the human genome is actually usefulmeaning it contains genes that code proteinsand the rest is junk DNA. Cambridge, MA-based RaNA Therapeutics was founded on the idea that the so-called junk is actually gold, because it contains a type of RNA that can flip genes on inside cells, potentially offering a new approach to modulating diseases.RaNA is coming out of stealth mode today and announcing a $20.7 million Series A financing led by Atlas Venture, SR One, and agricultural giant Monsanto (NYSE: MON). Partners Innovation Fund also participated in the funding.

RaNA Raises $20.7M From Atlas, SR One, Monsanto, for RNA-Based Tech

What is RaNA Therapeutics?

RaNA Therapeutics is pioneering the discovery of a new class of medicines that target RNA to selectively activate protein expression, thereby enabling the body to produce desirable proteins to treat or prevent disease. RaNAs novel therapeutics work by precisely activating the expression of select genes within the patients own cells, increasing the synthesis of therapeutic proteins. The companys proprietary RNA targeting technology works epigenetically to make it possible, for the first time, to increase the expression of therapeutic proteins with exquisite selectivity.

http://ranarx.com/

This has the potential to turn on and silence, with a great degree of accuracy, gene expression in anyones body. For example,

The patchy colours of a tortoiseshell cat are the result of different levels of expression of pigmentation genes in different areas of the skin.

https://en.wikipedia.org/wiki/Gene_expression

Monsanto is not working at Curing world hunger through biotechnology. That is a successful smokescreen and marketing slogan gone viral. Edward Bernays, the father of marketing propaganda to the masses, would have been proud.

The Inevitable Conclusion

Remember the definition of reprogenetics in the beginning of this article? Reprogenetics is the genetic engineering of man to create a human race according to scientific design. Well, it is 2013, and we now have the tools to silence and turn on genes through RNA manipulation. And its coming to us courtesy of Monsanto, the chemical/life sciences company that brought us Agent Orange, PCBs, and most of the genetically engineered ingredients in 80% of the processed foods we eat every day.

We know that a pseudo-scientific agenda called Transhumanism, which is bankrolled by some very rich and influential people, is intended to change us as a species, knows no bounds, is set to replace biology as we know it and is inexorably connected to eugenics. We know that this Transhumanist agenda is well on its way to changing the world in ways that we cannot fathom, and we know that Monsanto is involved through its research and application of DNA manipulation techniques in our food supply. Happy eating, America

2013 Barbara H. Peterson

View post:
Transhumanism: Genetic Engineering of Man – the New …

Recommendation and review posted by G. Smith

Chem4Kids.com: Biochemistry: Enzymes

Posted: June 9, 2018 at 5:45 pm

We have a whole section where we tell you about reactions and the molecules that change in those reactions. Chemical bonds are being created and destroyed over a series of many intermediate reactions. Those changes rarely happen on their own when you look at biological systems.

Will a blob of protein in a Petri dish simply break down into amino acids? No. To break a protein down into its amino acids you will need enzymes. Enzymes are biological molecules (proteins) that act as catalysts and help complex reactions occur everywhere in life. Lets say you ate a piece of meat. Proteases would go to work and help break down the peptide bonds between the amino acids.

Will all enzymes break down all substances? No. Enzymes are very specific catalysts and usually work to complete one task. An enzyme that helps digest proteins will not be useful to break down carbohydrates. Also, you will not find all enzymes everywhere in the body. That would be inefficient. There are unique enzymes in neural cells, intestinal cells, and your saliva.

The robot that was designed to move a car door can’t put brakes on the car. The specialized robot arms just can’t do the job. Enzymes are the same. They can only work with specific molecules and only do specific tasks. Because they are so specific, their structure is very important. If only one amino acid of the enzyme is messed up, the enzyme might not work. It would be as if someone unplugged one of the cords in a robot.

For example, some herbicides are used to block plant enzyme activity. A tiny herbicide molecule can attach to the active site of an enzyme and stop it from working. Plants have adapted by changing one or two amino acids in their enzymes. They adjust their structure, are able to continue working, and the herbicide can no longer limit the enzyme.

2. The enzyme grabs on to the substrate at a special area called the active site. The combination is called the enzyme/substrate complex. Enzymes are very, very specific and don’t just grab on to any molecule. The active site is a specially shaped area of the enzyme that fits around the substrate. The active site is like the grasping claw of the robot on the assembly line. It can only pick up one or two parts.

3. A process called catalysis happens. Catalysis is when the substrate is changed. It could be broken down or combined with another molecule to make something new. It will break or build chemical bonds. When done, you will have the enzyme/products complex.

4. The enzyme releases the product. When the enzyme lets go, it returns to its original shape. It is then ready to work on another molecule of substrate.

Read the original post:
Chem4Kids.com: Biochemistry: Enzymes

Recommendation and review posted by G. Smith

Regenerative Medicine – directorthocare.com

Posted: June 7, 2018 at 5:41 pm

Regenerative medicine is a game-changer in the world of medicine. Treatments include: Stem Cell Therapy, PRP (Platelet Rich Plasma) Therapy and Amniotic Stem Cell Therapy (Amnion). Each custom treatment option may help to heal damaged tissues and organs, offering solutions and hope for people whose conditions have proven beyond repair previously.

I didnt know anything about PRP when I went to my appointment with Dr. Hall. I was able to do some research before I had anything done. The stem cells come from my own bone marrow. Stem cell treatment is fairly new, but shows positive results. I decided that it was something that could help me. I trust Dr. Hall. Dr. Hall removed the stem cells from my hip and injected them into my knees while I was in surgery under anesthesia.

I was in physical therapy after the surgery. Now Im back in the gym three days a week, exercising on the elliptical machine, weight training and in yoga classes. I walk five miles four or five days a week.

In six weeks, I was at 133 degrees range of motion, which was only 4 degrees behind my good leg. I attribute my advanced recovery to the outstanding hands of the DOC surgeon, the PRP/stem cell therapy, and Mike at ATI Physical Therapy.I attribute my advanced recovery to the outstanding hands of the DOC surgeon, the PRP/stem cell therapy, and Mike at ATI Physical Therapy.

If you are reading this testimonial and questioning whether the extra money spent on the PRP and stem cell therapy are worth it, I would highly recommend that you take out a loan if necessary in order to benefit from this healing therapy.

Continue reading here:
Regenerative Medicine – directorthocare.com

Recommendation and review posted by G. Smith

Genome Editing for Hemophilia: A Next Step in Genetic …

Posted: June 7, 2018 at 2:44 am

Using an innovative gene therapy technique called genome editing that hones in on the precise location of mutated DNA, scientists have treated hemophilia, a blood clotting disorder, in mice.

This is the first time that genome editing, which precisely targets and repairs a genetic defect, has been done in a living animal and achieved clinically meaningful results. The study appeared online in Nature in June 2011.

As such, it represents an important step forward in the decades-long scientific progression of gene therapy developing treatments by correcting a disease-causing DNA sequence. In this study, researchers used two versions of a genetically engineered virus (adeno-associated virus, or AAV):

All of this occurred in the liver cells of living mice.

Our research raises the possibility that genome editing can correct a genetic defect at a clinically meaningful level after in vivo delivery of the zinc finger nucleases, said study leader, Katherine A. High, MD, a hematologist and gene therapy expert at The Childrens Hospital of Philadelphia. High, an investigator for Howard Hughes Medical Institute, directs the Center for Cellular and Molecular Therapeutics at Childrens Hospital, and has investigated gene therapy for hemophilia for more than a decade.

Highs research, in collaboration with scientists at Sangamo BioSciences, Inc., uses genetically engineered enzymes called zinc finger nucleases (ZFNs) which act as molecular word processors, editing mutated sequences of DNA. Scientists have learned how to design ZFNs custom-matched to a specific gene location. ZFNs specific for the factor 9 gene (F9) were designed and used in conjunction with a DNA sequence that restored normal gene function lost in hemophilia.

By precisely targeting a specific site along a chromosome, ZFNs have an advantage over conventional gene therapy techniques that may randomly deliver a replacement gene into an unfavorable location, bypassing normal biological regulatory components controlling the gene. This imprecise targeting carries a risk of insertional mutagenesis, in which the corrective gene causes an unexpected alteration, such as triggering leukemia.

In hemophilia, an inherited single-gene mutation impairs a patients ability to produce a blood-clotting protein, leading to spontaneous, sometimes life-threatening bleeding episodes.

The two major forms of the disease, which occurs almost solely in males, are hemophilia A and hemophilia B. Hemophilia A is caused by a lack of clotting factor VIII; hemophilia B is cause by a lack of clotting factor IX.

Patients are treated with frequent infusions of clotting proteins, which are expensive and sometimes stimulate the body to produce antibodies that negate the benefits of treatment.

In this study, researchers used genetic engineering to produce mice with hemophilia B, modeling the disease in people. Before treatment, the mice had no detectable levels of clotting factor IX.

Previous studies by other researchers had shown that ZFNs could accomplish genome editing in cultured stem cells that were then injected into mice to treat sickle cell disease. However, this ex vivo approach is not feasible for many human genetic diseases, which affect whole organ systems. Therefore the current study tested whether genome editing was effective when directly performed in vivo (in a living animal).

High and colleagues designed two versions of a vector, or gene delivery vehicle, using adeno-associated virus (AAV). One AAV vector carried ZFNs to perform the editing; the other delivered a correctly functioning version of the F9 gene. Because different mutations in the same gene may cause hemophilia, the process replaced seven different coding sequences, covering 95 percent of the disease-carrying mutations in hemophilia B.

The researchers injected mice with the gene therapy vector, which was designed to travel to the liverwhere clotting factors are produced. The mice that received the ZFN/gene combination then produced enough clotting factor to reduce blood clotting times to nearly normal levels. Control mice receiving vectors lacking the ZFNs or the F9 minigene had no significant improvements in circulating factor or in clotting times.

The improvements persisted over the eight months of the study, and showed no toxic effects on growth, weight gain or liver function clues that the treatment was well-tolerated by the mice.

We established a proof of concept that we can perform genome editing in vivo, to produce stable and clinically meaningful results, High said. We need to perform further studies to translate this finding into safe, effective treatments for hemophilia and other single-gene diseases in humans, but this is a promising strategy for gene therapy.

The clinical translation of genetic therapies from mouse models to humans has been a lengthy process, nearly two decades, but we are now seeing positive results in a range of diseases from inherited retinal disorders to hemophilia, she added. In vivo genome editing will require time to mature as a therapeutic [treatment], but it represents the next goal in the development of genetic therapies.

The Childrens Hospital of Philadelphia and the CCMT, directed by High, have pioneered the development of clinically promising AAV-mediated gene therapies. High and her colleagues have conducted:

The latter trial, for congenital blindness, was also the first trial of gene therapy for a nonfatal disorder that was allowed to include pediatric subjects.

Support for this research came from the National Institutes of Health and the Howard Hughes Medical Institute. Highs co-authors were from The Childrens Hospital of Philadelphia, the University of Pennsylvania, and Sangamo BioSciences, Inc. of Richmond, CA.

Li H1, Haurigot V, Doyon Y, Li T, Wong SY, Bhagwat AS, Malani N, Anguela XM, Sharma R, Ivanciu L, Murphy SL, Finn JD, Khazi FR, Zhou S, Paschon DE, Rebar EJ, Bushman FD, Gregory PD, Holmes MC, High KA. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature. 2011 Jun 26;475(7355):217-21. doi: 10.1038/nature10177.Read the abstract.

More:
Genome Editing for Hemophilia: A Next Step in Genetic …

Recommendation and review posted by G. Smith

Top Nanomedicine Conferences|DrugDelivery meetings …

Posted: June 7, 2018 at 2:42 am

About Us

2nd,International Conference and Exhibition on Nanomedicine and Drug Delivery May 21-23, 2018 Tokyo, Japan

ConferenceSeries Ltdis a renowned organization that organizes highly notablePharmaceutical Conferencesthroughout the globe. Currently we are bringing forth2ndInternational Conference on Nanomedicine and Drug Delivery(NanoDelivery 2018) scheduled to be held duringMay 21-23, 2018 at Tokyo, Japan. The conferenceinvites all the participants across the globe to attend and share their insights and convey recent developments in the field of Nanomedicine and Drug Delivery.

ConferenceSeries Ltdorganizes aconference seriesof 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientificsocietiesand publishes 700+Open access Journalswhich contains over 50000 eminent personalities, reputed scientists as editorial board members.

2018 Highlights:

Nanomedicine and drugdelivery will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nano medicine and drug delivery respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as Japan, China, India and other economies in the region. Japan is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.This conference seeks to showcase work in the area of Nanomedicine, Drug Delivery Systems, and nanotechnology, Nanobiothechnology, particularly related to drug delivery.

For More PS:https://nanomedicine.pharmaceuticalconferences.com/

(Click here for any queries)

Nanomedicine and drugdelivery can address one of the greatest challenges in the post-genomic era of the 21st century making the essential connections between Academics and industry professionals.

To meet these challenges, the field of Nanomedicine and drugdelivery has undergone exponential growth during the last 5 years. Technologies such as Personalized Nanomedicine, Design of Nanodrugs, Synthesis of Nanoparticles for Drug Delivery, Regenerative Medicine and Tissue Engineering, Nanomedicines and Biomedical applications, Nanomaterials for drug delivery, Regulatory Aspects Towards Approval of Nanomedicine, NanoPharmaceutical, Industry and Market processing and drug delivery promise to transform the world of Advanced nanomedicines and drug delivery much in the same way that integrated and transformed the world of pharmaceutical sciences.

Nanodelivery 2018 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in nanomedicine and drug delivery, where all attendees can interact with the panel followed by a Q&A session.

Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial board meeting: Discussing on growth and development of open access Nanomedicine and drugdelivery International Journals and recruiting board members and reviewers who can support the journal.

Round table meetings: Providing a platform where industry professionals meet academic experts.

Over 50+ organizations and international pavilions will be exhibiting at the Nanodelivery 2018 conference and Exhibition. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will see at the Nanodelivery Exhibition, you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from todays industry leaders.

The Nanodelivery 2018 has everything you need, all under one roof, saving you both time and money. It is the event you cannot afford to miss!

Who’s Coming to Nanodelivery 2018?

Nanomedicine:

Nanomedicineis the medical application ofnanotechnology, nanomedicineranges from the medical applicationsofnanomaterialsandbiological devices, to nanoelectronicbiosensors, and even possible future applications of molecular nanotechnology such asbiological machines.

Nanomedicine : Future Nanomedicine:

We can say that nanomedicine is ourfuture medicine.The usage ofNanomedicine in drug deliverycan unlock the way to cure many life threatening diseases. For examplesnanomedicine in cancer treatment,Nanomedicine for blood disorders,Nanomedicine for Lung Diseases, Nanomedicine for Cardiovascular Diseases. This includesFuture aspects of Nanomedicine,nanobots,nanodrugs.

Nanomedicine research group:

This is only possible by the grace and smart work of thenanomedicine research groupfrom all over the world.Nanomedicine coursesare taught in theuniversities all over the world.They also providepostdoctoral fellowship opportunity in nanomedicine.So we can say thatfuture of nanomedicineshines brightly .

Nanomedicine Market:

Nanomedicinecan be explained as theapplication ofnanotechnologytoachieveinnovation in healthcare.Theglobal nanomedicine marketis anticipatedto reach USD 350.8 billion by2025.This includes:Scope of Nanomedicine,Novel Drugs to NanoDrugs,Nanodrugs for Herbal medicinesand Cosmetics

Nanomedicine in Cancer:

A wide range of new tools and possibilities is already achieved incancer treatments using Nanotechnology, fromdiagnosingit earlier to improvedimagingfortargeted therapies.This includes Nanomedicine for other disease,Nanomedicine for Cardiovascular Diseases,Nanodrugs for Cancer Therapy

New formulations:

Nanomedicines are three-dimensional constructs of multiple components with preferred spatial arrangements for their functions.This includesNano Sized Drugs,Nanodrugs for Veterinary Therapeutics,Nanodrugs for Medical applications,Formulation and Development.

Emergence of Nanomedicines:

Extensive multidisciplinary investigation in the field ofnanomedicine nanotechnology biology and medicinehas caused the emergence of Nanomedicine as promising carriers fordeliveryof diversetherapeutic moleculesto the targeted sites. This includesNanodrugs for Cancer Therapy,Nanodrugs for Veterinary Therapeutics,Nanodrugs for Medical applications.

VLPs:

VLPsare a viruses devoid ofgenetic materialand thus they cannotreplicate.This includesNanoMedicine in HIV,Drug targeting,Nanomedicine for Cancer.

Nanocarrier :

A nanocarriers are used as atransport modulefor adrug. Commonly usednanocarriersincludemicelles,polymers,carbon-based materials,liposomesandmany more.This includesnanoparticles,nanobots,nanodrugs.

Nanomedicine-History:

It was the extensive multidisciplinary investigation in the field ofnanomedicine nanotechnologybiology and medicinethat gave rise to thefuture medicinei.e.Nanomedicine. We know that nanotechnology is a recent development inscientific research,though the development of its central concepts happened over a longer period of time.This includesNanomedicine for other disease,Nanodrugs for Herbal medicines and Cosmetics

Biomedical nanotechnology:

Biomedical nanotechnologyincludes a diverse collection of disciplines.This includesCarbon Nanotubes,BiosensorsandNanobioelectronics,Nanobiomechanics and Nanomedicine.

Drug delivery systems:

Drug deliveryis theformulations,technologies, and systems for transporting apharmaceutical compoundinside the body safely to achieve itsdesired therapeutic effect.This includesLiposomes,Versatile Polymers In Drug Deivery,Drug Development

Toxicity:

Toxicityis the measure to which a particular mixture of substances can damage an organism.This includeGold Nanoparticles,Silver Nanoparticles,Magnetic Nanoparticles.

Xenobiotics:

Axenobioticis a chemical substances which is not produced naturally or expected to be found within an organism.This includesNano Micro Particles,BiosensorsandNanobioelectronics,Bio inspired materials and drug delivery

Pharmaceutical technology:

We can detect diseases at much earlier stages usingNano pharmaceuticals.Usingnanoparticles we can also design thediagnostic applicationsconventionally.This includesNanoliposome,Drug Targeting,Challenges and advances in NanoPharmaceuticals

Bioimaging:

Bioimagingare methods that non-invasively visualizebiological processesin real time.This includesImage-guided drug delivery,Imaging,Optical sensors

Imaging probe:

Molecular imaging probeis an agent used tovisualize, characterize and quantify biological processes in living systems .This includesOptical sensors,Smart Polymer Nanoparticles,NanomaterialsforImaging

Pharmaceutical compound:

The particular pharmaceutical product to fit the unique need of a patient can be made byPharmaceutical compounding.This includesChallenges and advances in Nano Pharmaceuticals,Nano Pharmaceuticalsfrom thebench to Scale up

Pulmonary delivery:

Pulmonary deliveryofdrughas become an attractive target and of tremendous scientific andbiomedical interestin thehealth care research.This includes Transmucosal Drug Delivery Systems, Sonophoresis Drug Delivery System, Hydrogel in Drug Delivery

Vascular disease:

Diseases of theblood Vessels can be related toVascular diseases.This includesovarian, breast cancer,kidney disease,fungal infections.

Tissue engineering:

The use of a tissue, engineering and materials methods, and suitablebiochemicalandphysicochemical factorsto improve or replacebiological tissues.This includesNeuro Regenerations,Organ fabrication,Cell-based therapies

Regenerative medicine:

Regenerative medicineis a broad field that includes tissue engineering but also incorporates onself-healing

Regenerative medicine- self healing:

Body uses its own systems, sometimes with help foreignbiological materialtorecreate cellsandrebuild tissuesand organs.This includeBiologic scaffolds,Bone Marrow Tissue Engineering,Mechanical properties of engineered tissues

Quantitative Imaging:

Quantitative imagingprovides clinicians with a more accurate picture of a disease state.This includesImage-guided drug delivery,Imaging,Optical sensors.

Tissue Sciences:

The internal organs and connective structures ofvertebrates, andcambium,xylem, andphloemin plants are made up of different types of tissue.This includesNeuro Regenerations,Bioreactor design,Bone Marrow Tissue Engineering.

Rational drug design:

Drug design, is simply the inventive process of findingnew medicationsbased on the knowledge of abiological targetThis includesNanodrugs for Cancer Therapy,Nanodrugs for Medical applications,Nano Sized Drugs

Drug target:

Biological targetcan be described as thenative proteinin the body , with modified activity by a drug resulting in a specific effect. The biological target is often referred to as a drug target.This includeDrug targeting,Image-guided drug delivery,target site

Drug resistance mechanism:

InDrug resistancethe effectiveness of amedicationis reduced such as anantimicrobialor anantineoplasticin curing a disease or condition.This includeschemotherapy,tumor-targeted drug delivery

Single molecule imaging:

Single-molecule studies may be contrasted with measurements on the bulk collection of molecules. In this individual behavior ofmoleculescannot be distinguished, and only average characteristics can be measured.This includeDrug targeting,Image-guided drug delivery,Imaging

Medicine:

Medicine can be explained as the science and practice of thediagnosis,treatment, andprevention of disease.This include Controledradical polymerization,Nanodrugs for Herbal medicinesandCosmetics,Nanomedicine for Gastrointestinal Tract (GI) Diseases.

Computer-Aided Diagnosis:

Computer-aided detection(CADe), are systems that help doctors in the interpretation ofmedical images.This includesImage-guided drug delivery,Optical sensors,BiosensorsandNanobioelectronics

Pharmacology:

Pharmacology is the study ofdrug action, where a drug can be broadly defined as any man-made, natural, or endogenousThis includesNanoliposome,Drug Targeting,Applied biopharmaceutics

Drug delivery industries:

Demand fordrug deliveryproducts in the US will rise 6.1 percent yearly to $251 billion in 2019. Parenteral products will grow the fastest, driven bymonoclonal antibodiesandpolymer-encapsulated medicines.Hormonesand central nervous system agents will lead gains by application.Pen injectorsand retractable prefillable syringes will pace devices.This includesBio Pharmaceutical Industry,Focus on Nanopharmaceuticals,Industrial Applications of Nano medicine.

Drug delivery market:

The drug delivery market is thelargest contributing applicationsegment, whereasbiomaterialsis the fastest growing application area in this market. Nanomedicine accounts for 77Marketed ProductsWorldwide, representing an Industry with an estimated market $130.9 Billion by 2016.This includesBio Pharmaceutical Industry,Focus on Nanopharmaceuticals,Industrial Applications of Nano medicine.

Nanomedicine Market Size:

Theglobal nanomedicine marketis anticipated to reach USD 350.8 billion by 2025, according to a new report by Grand View Research, Inc. Development ofnovel nanotechnology-based drugsandtherapiesis driven by the need to develop therapies that have fewer side effects and that are morecost-effectivethantraditional therapies, in particular for cancer.This includespharmaceutical industry,Up Coming Market for Nanotechnology,Focus on Nanopharmaceuticals.

Biodegradable implants:

Biodegradable implants offer a number of financial,psychological, andclinical advantagesoverpermanent metal implants.They provide the appropriate amount of mechanical strength when necessary, and degrade at a rate similar tonew tissue formation, thereby transferring the load safely to thehealed boneand eliminating the need for an additional revision and removal operation.This includesBiologic scaffolds,Biomaterials,Bone Marrow Tissue Engineering.

Nanomedicine industry:

Expecteddevelopments in nanoroboticsowing to therise in fundingfrom thegovernment organizationsis expected to induce potential to the market.Nanorobotics engineering projectsthat are attempting totarget the cancer cellswithout affecting the surrounding tissues is anticipated to drive progress through to 2025.This includesIndustrial Applications of Nano medicine,Nanotechnology tools in Pharmaceutical R&D,Bio Pharmaceutical Industry,Focus on Nanopharmaceuticals

Nanomedicine Market Drivers:

The major drivers of the nanomedicine market include its application in varioustherapeutic areas, increasingR&D studiesabout nanorobots in this segment, andsignificant investmentsinclinical trialsby the government as well as private sector. TheOncology segmentis the majortherapeutic areafornanomedicine application, which comprised more than 35% of the total market share in 2016.This includesAn Up and Coming Market for Nanotechnology,Nanomedicine: Prospects, Risks and Regulatory Issues,Current , Future Applications and Regulatory challenges.

Nanomedicine Market trends:

Thetherapeutic areas for nanomedicineapplication areOncology,is includesCurrent , Future Applications and Regulatory challenges,Regulatory Policies.

Nanomedicine Market Forecast:

Read the original:
Top Nanomedicine Conferences|DrugDelivery meetings …

Recommendation and review posted by G. Smith


Page 20«..10..19202122..3040..»